These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 26518473
21. Assessement of postoperative long-term survival quality and complications associated with radical antegrade modular pancreatosplenectomy and distal pancreatectomy: a meta-analysis and systematic review. Zhou Q, Fengwei-Gao, Gong J, Xie Q, Liu Y, Wang Q, Lei Z. BMC Surg; 2019 Jan 28; 19(1):12. PubMed ID: 30691444 [Abstract] [Full Text] [Related]
22. Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sided Pancreatic Cancer: A Meta-Analysis and Experience of a Single Center. Huo Z, Zhai S, Wang Y, Qian H, Tang X, Shi Y, Weng Y, Zhao S, Deng X, Shen B. Med Sci Monit; 2019 Jun 21; 25():4590-4601. PubMed ID: 31221951 [Abstract] [Full Text] [Related]
24. Laparoscopic radical antegrade modular pancreatosplenectomy (RAMPS) for adenocarcinoma of the body and tail of the pancreas - technical considerations with analysis of surgical outcomes. Borys M, Wysocki M, Gałązka K, Stanek M, Budzyński A. Langenbecks Arch Surg; 2024 Feb 24; 409(1):74. PubMed ID: 38400929 [Abstract] [Full Text] [Related]
25. Laparoscopic subtotal pancreatectomy with radical antegrade modular pancreatosplenectomy for left-sided pancreatic cancer. Kim S, Yoon YS, Han HS, Cho JY. Surg Oncol; 2019 Mar 24; 28():150. PubMed ID: 30851891 [Abstract] [Full Text] [Related]
26. Surgical and oncological outcomes of laparoscopic versus open radical antegrade modular pancreatosplenectomy for pancreatic ductal adenocarcinoma. Hirashita T, Iwashita Y, Fujinaga A, Nakanuma H, Tada K, Masuda T, Endo Y, Ohta M, Inomata M. Surg Today; 2022 Feb 24; 52(2):224-230. PubMed ID: 34173053 [Abstract] [Full Text] [Related]
27. [Laparoscopic radical antegrade modular pancreatosplenectomy for left-sided pancreatic adenocarcinoma: analysis of 12 cases]. Xu XW, Zhang RC, Mou YP, Qian ZY, Huang CJ, Zhu QC, Jin WW, Zhou YC. Zhonghua Wai Ke Za Zhi; 2018 Mar 01; 56(3):212-216. PubMed ID: 29534416 [Abstract] [Full Text] [Related]
28. A systematic review of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas. Zhou Y, Shi B, Wu L, Si X. HPB (Oxford); 2017 Jan 01; 19(1):10-15. PubMed ID: 27553838 [Abstract] [Full Text] [Related]
29. Comparison of minimal invasive versus open radical antegrade modular pancreatosplenectomy (RAMPS) for pancreatic ductal adenocarcinoma: a single center retrospective study. Zhang H, Li Y, Liao Q, Xing C, Ding C, Zhang T, Guo J, Han X, Xu Q, Wu W, Zhao Y, Dai M. Surg Endosc; 2021 Jul 01; 35(7):3763-3773. PubMed ID: 33033915 [Abstract] [Full Text] [Related]
31. Surgical outcome of pancreatic cancer using radical antegrade modular pancreatosplenectomy procedure. Chang YR, Han SS, Park SJ, Lee SD, Yoo TS, Kim YK, Kim TH, Woo SM, Lee WJ, Hong EK. World J Gastroenterol; 2012 Oct 21; 18(39):5595-600. PubMed ID: 23112553 [Abstract] [Full Text] [Related]
34. Laparoscopic radical antegrade modular pancreatosplenectomy: preliminary experience with 10 cases. Zhang RC, Gan XJ, Song W, Shi ST, Yu HF, Mou YP. BMC Surg; 2021 Feb 10; 21(1):78. PubMed ID: 33568109 [Abstract] [Full Text] [Related]
35. Radical antegrade modular pancreatosplenectomy (RAMPS) versus standard retrograde pancreatosplenectomy (SRPS) for resectable body and tail pancreatic adenocarcinoma: protocol of a multicenter, prospective, randomized phase III control trial (CSPAC-3). Li J, Shi S, Liu J, Liang C, Hua J, Meng Q, Xu H, Wei M, Zhang B, Xu J, Wang W, Yu X. Trials; 2023 Aug 17; 24(1):541. PubMed ID: 37592267 [Abstract] [Full Text] [Related]
37. Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: A retrospective propensity score-matched study. Qu L, Zhiming Z, Xianglong T, Yuanxing G, Yong X, Rong L, Yee LW. Int J Surg; 2018 Jul 17; 55():81-86. PubMed ID: 29802919 [Abstract] [Full Text] [Related]
38. Minimally invasive RAMPS in well-selected left-sided pancreatic cancer within Yonsei criteria: long-term (>median 3 years) oncologic outcomes. Lee SH, Kang CM, Hwang HK, Choi SH, Lee WJ, Chi HS. Surg Endosc; 2014 Oct 17; 28(10):2848-55. PubMed ID: 24853839 [Abstract] [Full Text] [Related]